To efficiently generate cardiomyocytes from embryonic stem (ES) cells in culture it is essential to identify key regulators of the cardiac lineage and to develop methods to control them. Using a tet-inducible mouse ES cell line to enforce expression of a constitutively activated form of the Notch 4 receptor, we show that signaling through the Notch pathway can efficiently respecify hemangioblasts to a cardiac fate, resulting in the generation of populations consisting of 460% cardiomyocytes. Microarray analyses reveal that this respecification is mediated in part through the coordinated regulation of the BMP and Wnt pathways by Notch signaling. Together, these findings have uncovered a potential role for the Notch pathway in cardiac development and provide an approach for generating large numbers of cardiac progenitors from ES cells.
The efficient and reproducible differentiation of ES cells to the cardiovascular lineages will provide an unlimited, renewable source of cardiomyocytes for the development of cell-based therapies for cardiovascular disease, for designing new platforms for drug discovery and toxicology testing, and for establishing in vitro models of congenital cardiac abnormalities. Although cardiomyocytes have been generated from both mouse and human ES cells, the differentiation protocols used in most studies have not been optimized for the cardiac lineage, yielding limited numbers of the desired cell type in mixedlineage cultures (reviewed in ref. 1) . To achieve efficient differentiation of ES cells to the cardiovascular lineages, it is essential to recapitulate in the differentiation cultures the developmental pathways that regulate the commitment of these lineages in vivo. In the early embryo, the cardiac lineage develops from mesodermal cells that are specified early in embryonic life, shortly after the formation of hematopoietic mesoderm 2, 3 . Studies with the ES cell model have successfully reproduced this temporal pattern of hematopoietic and cardiac development and in doing so have identified progenitors that display both tissue-specific and vascular potential [4] [5] [6] [7] [8] [9] [10] . Within the hematopoietic system this progenitor, known as the hemangioblast, has been defined as a Flk-1 + (kinase insert domain receptor, KDR + ) progenitor that is able to generate cells of the hematopoietic, endothelial and vascular smooth muscle lineages [4] [5] [6] [11] [12] [13] . A similar multipotential progenitor has been recently identified for the cardiovascular lineages [7] [8] [9] [10] . Following isolation and differentiation in culture, this progenitor, which also expresses Flk-1, is able to give rise to a population highly enriched for cardiomyocytes and vascular cells 7, 10 .
Although the mechanisms controlling the temporal aspects of mesoderm induction are poorly understood, both the bone morphogenetic protein (BMP) and Wnt signaling pathways play pivotal roles in the specification of mesoderm to the cardiac lineage [14] [15] [16] [17] [18] [19] [20] [21] [22] . BMP appears to promote cardiac specification [14] [15] [16] , whereas Wnt signaling has differential stage-specific effects, functioning in either an agonistic or antagonistic fashion [17] [18] [19] [20] [21] [22] . Notch signaling also influences cardiac development [23] [24] [25] , although its precise role is not well established. Manipulation of the pathway in different systems points to an inhibitory role in cardiac development. For instance, activation of Notch1 in the heart field of the Xenopus embryo decreases expression of cardiac genes 23 . ES cells deficient in the Notch downstream effector RBP-Jk generate more cardiomyocytes than wild-type counterparts 24 , whereas ES cells expressing a constitutively active form of the Notch1 receptor display reduced cardiac potential 25 . Although these studies collectively show that Notch signaling is inhibitory at specific stages of the cardiac lineage, the expression patterns of Notch receptors suggest that this pathway could play additional roles in cardiac development, as most are expressed in the mesoderm of the gastrulating embryo 26 as well as in the cardiovascular lineages at different stages [26] [27] [28] [29] [30] .
As Notch signaling is involved in lineage specification in many different organisms, we were interested in determining whether manipulation of this pathway could influence cardiac development in mouse ES cell cultures. For these studies we focused on Notch4, because its expression is restricted to the endothelial component of the heart 30 , suggesting that it could function at the level of cardiovascular progenitor development and/or specification to derivative cell types. In this report we show that Notch signaling promotes cardiac development from cardiac mesoderm and is able to respecify Flk-1 + hemangioblasts to a cardiac cell fate. These effects of Notch signaling are stage specific and mediated partially through activation of BMP signaling and inhibition of the Wnt pathway. These findings demonstrate a role for Notch signaling in the specification of mesoderm to derivative lineages and provide an efficient approach to generate large numbers of cardiovascular cells.
RESULTS
Notch regulates cardiac differentiation from mesoderm After 3.0-3.5 d of serum stimulation, the ES cell line containing the green fluorescent protein (GFP) cDNA targeted to the brachyury locus (Bry-GFP) generates three distinct populations based on Flk-1 and GFP expression: Bry-GFP -/Flk-1 -, Bry-GFP + /Flk-1and Bry-GFP + / Flk-1 + (Fig. 1a) 11, 12 . Functional studies have shown that the Bry-GFP + /Flk-1 + population contains hemangioblasts whereas the Bry-GFP + /Flk-1population (cardiac mesoderm) displays cardiac potential 12 . When cultured as aggregates in suspension for 24 h, Bry-GFP + /Flk-1 --but not Bry-GFP + /Flk-1 + -derived cells express Notch4 and the cardiac transcription factor Nkx2-5 ( Fig. 1b) , consistent with the cardiac potential of this fraction. After 3 d of culture on gelatin-coated surfaces in serum-free media, (hereafter referred to as cardiac cultures) the Bry-GFP + /Flk-1 --derived aggregates mature to generate contracting cardiomyocytes.
To evaluate the role of Notch signaling in the establishment of the cardiac lineage from the Bry-GFP + /Flk-1cardiac mesoderm population, we used a tet-inducible ES cell line 31 engineered to express a constitutively activated Notch4 receptor, which contains the intracellular domain of Notch4 as well as the membrane-anchored sequence that requires cleavage by the ubiquitous enzyme g-secretase for activation 32 . The Notch4-inducible cell line also contains the GFP cDNA targeted to the brachyury locus (hereafter referred to as Bry-GFP/Ainv-Notch4 ES cells; Supplementary Fig. 1 online) . In the first set of experiments, Notch signaling was activated by doxycycline (Dox) induction in the Bry-GFP + /Flk-1 --derived population or inhibited by the addition of g-secretase inhibitor (GSI) to the cells either during the 24 h reaggregation step or during the cardiac culture stage. Induction of Notch4 within the aggregates (+Dox/-Dox) moderately enhanced cardiomyocyte development over the control (-Dox/-Dox) as demonstrated by an increase in the proportion of cardiac troponin-T (cTnT) + cells ( Fig. 1c) . When induced at a later stage during the maturation of the population in the cardiac cultures (-Dox/+Dox), Notch4 expression had an opposite effect and led to a reduction in the frequency of cTnT + cells and in the expression of genes associated with cardiac maturation, including Actc1 (cardiac a-actin), Myh6 (cardiac mhc), My17 and My12 (Fig. 1c,d ). Addition of GSI to the Bry-GFP + /Flk-1population during the reaggregation stage (+GSI/-GSI) inhibited the development of cTnT + contracting cells and the expression of the cardiac genes ( Fig. 1e,f) . When added to the cardiac cultures (-GSI/+GSI), the Notch inhibitor enhanced cardiac development, as demonstrated by an increased size of the cTnT-expressing population ( Fig. 1e ). As expected, this population expressed the spectrum of cardiac genes ( Fig. 1f ). Together, these observations indicate that active Notch signaling in the Bry-GFP + /Flk-1mesoderm population promotes cardiac development and that this effect is stage specific.
Notch4 respecifies the Flk-1 + hemangioblast population to a cardiac fate
The Bry-GFP + /Flk-1 + population contains hemangioblasts (also known as blast colony forming cells (BL-CFC)) that are characterized by their ability to generate blast colonies comprising hematopoietic and vascular progenitors in methylcellulose cultures. If isolated and cultured for 2 d as aggregates in serum-containing media, Bry-GFP + / Flk-1 + cells generate hematopoietic cells, as demonstrated by emergence of CD41 + cells (-Dox, Fig. 2a ) and hematopoietic progenitors (-Dox, Fig. 2b ). Induction of Notch4 in the Bry-GFP + /Flk-1 + -derived aggregates for 2 d inhibited development of the CD41 + population and hematopoietic progenitors, indicating a marked reduction in hematopoietic potential (+Dox, Fig. 2a,b) . A moderate increase in the proportion of VE-cadherin + (VE-cad) endothelial cells was observed in the Notch4-induced aggregates ( Fig. 2a ). Molecular analysis confirmed these findings and revealed dramatically lower expression levels of the hematopoietic-specific gene Gata1 and moderately increased levels of genes indicative of endothelial and vascular smooth muscle development, including Flk-1 (also known as Kdr), VE-cad (also known as Cdh5), SM22 (also known as Tagln)and Pdgfbr (also known as Pdgfrb) ( Fig. 2c ) in the Notch-induced population compared with noninduced controls. Of particular interest was the observation that induction of Notch4 resulted in the upregulation of expression of the cardiac gene Nkx2-5 (ref. 33) ( Fig. 2c ), suggesting respecification of these cells to a cardiac fate. When cultured for an additional 3 d in cardiac conditions, Bry-GFP+/Flk-1+-derived aggregates induced with Dox for 24 h generated extensive areas of contracting cells (Supplementary Video 1 online) of which more than 60% expressed cTnT (+Dox/-Dox, Fig. 2d ), indicat-ing that this population was highly enriched for cardiomyocytes. Molecular analyses confirmed that the cells expressed a range of different cardiac genes ( Fig. 2e ). The control, noninduced population contained no contracting cells and did not express any of the cardiac genes or cTnT (-Dox/-Dox, Fig. 2d ,e, Supplementary Video 2 online). Induction of the cardiac program within the Bry-GFP + /Flk-1 + population by Notch4 was inhibited by the addition of GSI, indicating that the effect was due to active Notch signaling (+Dox+GSI/-Dox, Fig. 2d ,e). If Dox was maintained during the plating of the aggregates in the cardiac cultures, the size of the cTnT + population was significantly reduced and the expression of cardiac genes was downregulated (+Dox/ +Dox, Fig. 2d ,e), demonstrating that the cardiogenic effects were stage specific. Taken together, these findings show that transient activation of the Notch pathway in the hemangioblast population efficiently and rapidly respecifies it to a cardiac fate. The ability to respecify hemangioblast mesoderm was not unique to Notch4, as enforced expression of activated Notch1 in the Bry-GFP + / Flk-1 + population resulted in the development of contracting cTnT + populations ( Supplementary Fig. 2 online) . Kinetic analyses of embryoid bodies indicated that the target population for respecification is transient and restricted to the hemangioblast window of development. Flk-1 + cells isolated from day 3 and day 4 embryoid bodies but not those from day 5 upregulated expression of Nkx2-5 and generated contracting cells after Dox induction ( Fig. 3a,b) .
As an alternate method of activating the Notch pathway in the hemangioblast population, day 3.25 Flk-1 + cells were co-cultured with OP9-Dl1 stromal cells engineered to express the Notch ligand Deltalike 1 (ref. 34) . Following 3 d of culture, cTnT + (24%) contracting cells were detected in the cultures and their development was inhibited by GSI, indicating that the respecification could be mediated by signaling through endogenous Notch receptors ( Fig. 3c,d) . A much lower proportion of cTnT + cells (8%) developed from Bry-GFP + /Flk-1 + cells that were cultured with control OP9 cells not expressing Dl1 (Fig. 3e,f) .
Notch respecifies the BL-CFC to a cardiac fate
To determine whether the BL-CFC is the target of the Notch4-induced fate change, we cultured day 3.25 Flk-1 + cells in the blast colony assay 4 in the presence or absence of Dox. In the absence of Dox, this population generated typical blast colonies that appeared as grape-like clusters of cells. In the presence of Dox, these cells formed compact colonies of tightly packed cells that were easy to distinguish from the blast colonies (Fig. 4a ). The number of these compact colonies was similar to the number of blast cell colonies that developed in the noninduced cultures ( Fig. 4b) . Addition of GSI together with Dox inhibited the appearance of the compact colonies, indicating that their development was dependent on Notch signaling. Most of the compact colonies expressed genes indicative of cardiac, endothelial and vascular smooth muscle development ( Fig. 4c, left panel) . None expressed Gata1. As expected, the blast colonies expressed the endothelial genes as well as Gata1 but did not express appreciable levels of the cardiac genes ( Fig. 4c, right panel) . With extended time in the methylcellulose cultures, some of the compact colonies began contracting, indicating maturation of cardiac cells (Supplementary Video 3 online). When picked from the methylcellulose cultures and replated in microtiter wells in the cardiac culture conditions, B70% of the compact colonies generated contracting cells. Hemangioblast-derived blast colonies did not give rise to contracting cells under these conditions. Compact colonies grown on glass coverslips for 4 d in the presence of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF) generated adherent populations that consisted of cTnT + /smooth muscle actin (SMA) + cardiomyocytes, CD31 + endothelial cells, and SMA + /cTnTvascular smooth muscle (VSM) cells, as demonstrated by immunostaining ( Fig. 4d) . The expression profiles together with the immunostaining analyses strongly suggest that the compact colonies are colonies of cardiovascular cells.
To establish the clonality of the compact cardiovascular colonies, we performed a cell dose-response experiment in which different numbers of Bry + /Flk-1 + cells were plated in blast colony conditions in the absence or presence of Dox. The relationship between the number of blast or compact colonies and the number of cells plated was linear, with a slope approaching 1, indicating that each colony was generated from a single colony-forming unit (Fig. 4e) . Additionally, the number of compact and blast colonies generated at the different cell concentrations was the same, consistent with the notion that the compact colonies were derived from BL-CFCs.
To further investigate the relationship between the BL-CFCs and the progenitors that generate the compact colonies, we limited the exposure of the Bry + /Flk-1 + cells to Dox to 24-48 h in an attempt to identify progenitors that were not fully respecified, as assessed by their capacity to generate mixed hematopoietic/cardiac colonies. After induction the developing colonies were removed from the Doxcontaining methylcellulose and replated in hemangioblast methylcellulose supplemented with erythropoietin and interleukin (IL)-3 to promote the expansion of any hematopoietic cells. Within 5 d of culture, B20% of the colonies had a mixed morphology with an inner core of cells surrounded by hematopoietic-like cells ( Fig. 4f and Supplementary Fig. 3 online) . The remaining 80% were compact colonies, indicating that the respecification was almost complete after this period of induction. The cores within some of the mixed colonies began contracting after 7 d culture ( Supplementary Video 4 online) . When picked and replated in the cardiac cultures, approximately half of these mixed colonies generated contracting cells. Molecular analysis confirmed the presence of the hematopoietic, endothelial and cardiac lineages (Fig. 4g) . Together, these findings strongly support the interpretation that expression of Notch respecifies the fate of the BL-CFC from a progenitor with hematopoietic and vascular potential to one with cardiovascular potential.
Notch4 induction upregulates components of the BMP and Wnt pathways
Microarray analyses of induced and noninduced Bry-GFP + /Flk-1 +derived populations at 4, 12, 24, 48 and 96 h after Dox treatment revealed a rapid upregulation of expression of the Notch target genes Hes5 and Hey1 and of specific members of the BMP and Wnt signaling pathways (Fig. 5a) . Expression of Bmp2, Bmp6, Bmp7, Wnt2, Wnt4 (b-catenin-independent) and the Wnt inhibitors, Sfrp1 and Sfrp5 (Fig. 5b,c) were all upregulated after induction of Notch4. The expression patterns of the other BMP and Wnt family members did not change significantly. The upregulation of expression of transcription factors associated with cardiac development, including Nkx2.5, Isl1, Tbx5 and Tbx20 (Fig. 5d) , was detected 24 to 36 h after the onset of expression of the above signaling molecules. The results from the microarray analysis were confirmed by quantitative RT-PCR for a representative number of genes ( Supplementary Fig. 4 online) . Taken together, these observations suggest that the cardiogenic effects of Notch may be mediated, in part, through the coordinated regulation of the BMP and Wnt signaling pathways.
BMP, b-catenin-independent Wnt and sFRP1 promote cardiac differentiation
Given the findings from the microarray analysis, we investigated the effects of manipulating BMP and Wnt signaling on cardiac development in both the Bry-GFP + /Flk-1 + and the Bry-GFP + /Flk-1populations. The addition of Wnt3a to the Notch4-induced Bry-GFP + /Flk-1 + population completely abolished cardiac development, indicating that inhibition of b-catenin-dependent Wnt signaling is required for Notch-mediated cardiac induction (Fig. 6a, 3) . In contrast, the addition of Wnt5a, a Wnt ligand that signals through a b-cateninindependent pathway, had no effect on the cardiac induction of Notch (Fig. 6a, 4) . Inhibition of BMP signaling through the addition of BMP receptors 1A and 1B reduced the size of the Notch-induced cTnT + population, indicating that BMP plays a role at this stage of cardiac development (Fig. 6a, 5) . To determine whether it is possible to mimic the effects of Notch4 induction by manipulating both the BMP and Wnt pathways, BMP6, Wnt5a (used as an equivalent of b-cateninindependent Wnt4) and the Wnt inhibitor sFRP1 were added either alone or in combination to the noninduced Bry-GFP + /Flk-1 + population. When added individually, BMP6 and Wnt5a displayed little cardiogenic potential over a range of concentrations (data not shown). The addition of sFRP1 did induce low levels of cTnT + cells (data not shown). The combination of the factors and the inhibitor did generate a cTnT + population from the GFP + /Flk-1 + cells; however, the extent of cardiac development was never as large as that observed after Notch4 induction (Fig. 6b) . These findings suggest that other factors may be required for efficient respecification of the hemangioblast mesoderm to a cardiac fate.
In the next set of experiments, we investigated whether manipulating BMP and Wnt signaling can promote cardiac development of the Bry-GFP + /Flk-1population. In the absence of any manipulation, day 3.25 embryoid body-derived cells will generate cardiomyocytes after aggregation and subsequent plating in cardiac cultures. The addition of BMP receptors 1A and 1B completely inhibited the generation of cTnT + cells, indicating that BMP is required for this stage of cardiac development (Fig. 6c) . When added individually, sFRP1, Wnt5a and BMP6 did not significantly increase cardiac development from this population (data not shown). However, when added together, these factors substantially enhanced the generation of cTnT + cells (Fig. 6d) . We next evaluated the role of BMP and Wnt signaling on earlier-stage (day 3.0) Bry-GFP + /Flk-1cells that are unable to differentiate to the cardiac lineage without additional induction (Fig. 6e, 1) . Neither sFRP1 nor Wnt5a promoted cardiac development from this population ( Fig. 6e, 2,3) . In contrast, BMP6 did induce the formation of cTnT + cells (Fig. 6e, 4) . The level of cardiomyocyte development induced by BMP6 was enhanced by the addition of Wnt5a (Fig. 6e, 5) . As observed with the day 3.25 population, the addition of all three factors induced the highest level of cTnT + cells, resulting in the development of populations consisting of almost 50% cardiac cells (Fig. 6e, 6) . These findings demonstrate that the factors and inhibitors induced by Notch expression do regulate cardiac development from cardiac mesoderm.
DISCUSSION
The findings presented in this study indicate that Notch signaling can initiate cardiac-lineage specification in part through the coordinated activation of BMP signaling and the inhibition of the b-catenindependent Wnt pathway. The cardiogenic effects of Notch signaling were demonstrated in the normal progression of cardiac mesoderm (Bry-GFP + /Flk-1 -) to cardiomyocytes and in the dramatic respecification of hemangioblasts to cardiovascular progenitors. These progenitors appear to be similar to the cardiovascular progenitors (cardiovascular colony-forming cell; CV-CFC) that we recently identified 17 (Fig. 7) . However, their isolation was based on temporal patterns of Flk-1 development and required two cell sorting steps, limiting the routine generation of large numbers of such cells. The ability to respecify the Bry-GFP + /Flk-1 + hemangioblast population to a cardiovascular fate through activation of Notch signaling eliminates one sorting step, thereby providing ready access to large numbers of enriched cardiovascular cells for functional studies in vitro and in vivo.
Our microarray analysis revealed that Notch4 functions through the activation of BMP signaling and the inhibition of the canonical Wnt pathway. With respect to BMP signaling, our findings are in line with other studies demonstrating that BMP2, BMP6 and BMP7 are expressed in the developing heart 35 and that signaling through this pathway is required for cardiac development 16, 36 . The specific induction of Wnt4 and Wnt2 is striking and suggests that they may play early roles in the establishment of the cardiac lineage. Recent studies have shown that Wnt2 can direct cardiac differentiation from mesoderm 37, 38 . Wnt4 functions through the b-catenin-independent pathway, which inhibits the b-catenin-dependent pathway 39 . The upregulation of Wnt4 together with the Wnt inhibitors sFRP1 and sFRP5 after Notch4 induction may function to rapidly and efficiently inhibit b-catenin-dependent signaling, an event required for cardiac specification of mesoderm 17, 22 . Our functional analyses do indeed show that the combination of factors induced by Notch4, namely BMP, b-catenin-independent Wnt and the Wnt inhibitor sFRP1, display robust cardiogenic activity on the Bry-GFP + /Flk-1cardiac mesoderm population.
Our findings appear to be at odds with several studies demonstrating that signaling though the Notch pathway inhibits cardiac development. Activation of the Notch pathway in stage 18-19 Xenopus embryos was shown to suppress the expression of genes indicative of cardiac maturation 23 . Conversely, suppression of Notch signaling in these embryos enhanced the expression of cardiac markers. These effects appear to be at the level of development and maturation of the cardiac lineage rather than on its induction, as the embryos already express both Nkx2-5 and Gata4. The role for Notch signaling in cardiac induction that we have described in this study is on populations that represent earlier stages of development that do not yet express Nkx2-5 or, in the case of the BL-CFC, on populations undergoing differentiation to other lineages. When induced at later stages in the cardiac cultures, after induction of the cardiac program, Notch4 expression inhibited maturation of the cardiac lineage. These findings are consistent with those demonstrating that RBP-Jk-deficient ES cells or ES cells expressing an RBP-Jk inhibitory protein exhibit increased cardiomyogenesis compared with wild-type controls 24, 25 . Together, these findings indicate that RBP-Jk-mediated Notch signaling is not required for cardiac specification and negatively regulates specific stages of cardiomyogenesis. Given these observations, it is possible that the cardiogenic effects of Notch signaling described here are mediated through one of the previously described RBP-Jk-independent pathways [40] [41] [42] [43] [44] [45] [46] [47] . Ongoing experiments are aimed at addressing this possibility.
In summary, the findings reported here define a role for Notch signaling at the level of mesoderm specification for the establishment of the cardiac lineage. The rapid and efficient induction of cardiac development after Notch induction in the Flk-1 + hemangioblast mesoderm provides an approach for efficiently and reproducibly generating cardiovascular cells from ES cells. This approach provides ready access to cardiovascular progenitors and more mature populations for both in vitro and in vivo functional analysis as well as for developmental biology studies aimed at defining the earliest molecular program involved in the specification of this lineage. Information obtained from such approaches with mouse ES cells will provide insights into the signaling pathways that regulate the establishment of the cardiac lineage from human ES cells.
METHODS
ES cell culture and differentiation. ES cells were maintained on irradiated feeders in DMEM supplemented with 15% FCS (FCS), 10% ES cellconditioned medium, penicillin, streptomycin, 1.5 Â 10 À4 M monothioglycerol (MTG; Sigma) and LIF (1% conditioned medium). Before induction of differentiation, cells were passaged two times on gelatin-coated plates in Iscove Modified Dulbecco Medium (IMDM) containing the same supplements mentioned above to deplete the population of feeder cells. For the generation of embryoid bodies, the cells were harvested and cultured in 60 mm lowattachment Petri-grade dishes (VWR) with IMDM supplemented with 2 mM L-glutamine (Gibco/BRL), 200 mg/ml transferrin (Boehringer Mannheim), 0.5 mM ascorbic acid (Sigma), 4 Â 10 À4 M MTG plus 15% FCS. For reaggregation cultures to support the differentiation of the hematopoietic and vascular lineages, 3 Â 10 5 Flk-1 + cells/ml were cultured for 2 d in ultra-low attachment 24-well plates (Corning Costar) with the same embryoid-body differentiation medium plus 5% protein-free hybridoma medium-II (PFHM-II, Invitrogen).
Notch4-inducible ES cells. The activated form of Notch4 cDNA (int-3) 27 tagged with hemagglutinin (HA) sequence was obtained from J. Kitajewski. The tet-on inducible ES cell line, Ainv18, obtained from M. Kyba was further modified by targeting the EGFP cDNA into the brachyury locus as described in our earlier study 11 . The Notch4 cDNA was introduced into the Ainv 18 and the modified Ainv ES cell lines by the approach previously described 31 . Briefly, the cDNA fragment of the activated form of Notch4 tagged with HA was inserted into the plox plasmid by convenient restriction sites to generate plox-Notch4/ HA. Ainv18 and the modified cell line were targeted with plox-Notch4/HA by co-electroporation of 40 mg each of plox-Notch4/HA and the Cre recombinase expression plasmid, pSalk-Cre. Positive clones were screened in ES medium with 300 mg/ml G418 (GIBCO) and isolated to generate inducible cell lines Bry-GFP/Ainv-Notch4. The positive clones were confirmed by immunohistochemistry detecting HA expression after induction.
Flow cytometry. Dissociated cells were incubated with biotinylated monoclonal antibodies (against Flk-1, VE-cad or CD41) in PBS containing 10% FCS on ice for 30 min. The cells were then washed once and incubated with streptavidin-PE-Cy5 (BD Pharmingen) for another 30 min on ice. After an additional two washes, the cells were analyzed on a FACSCalibur flow cytometer (Becton Dickinson) or sorted on a Moflo cell sorter (Cytomation). For Troponin T or HA staining, cells were fixed in 4% paraformaldehyde for 30 min and then incubated in a permeabilizing buffer consisting of PBS with 10% FCS and 0.1% saponin (Sigma) for 10 min. After fixing and permeabilization, the cells were washed twice and incubated with an anti-Troponin T (unconjugated mouse antibody, Lab Vision) or anti-HA (conjugated with biotin, Covance) antibody for 30 min. After two washes, the cells were incubated with a secondary APCconjugated goat anti-mouse antibody (for Troponin T antibody BD pharmingen) or streptavidin-PE-Cy5 (for biotinylated HA antibody) for 30 min. Finally, the cells were washed twice with permeabilizing buffer and then twice with buffer without saponin.
Colony assays. The blast and hematopoietic colony assays were performed as described 4 . Dox was added at 0.5 mg/ml to induce Notch4 expression and g-secretase inhibitor X (Calbiochem) at 5 mM to block Notch signaling in the blast colony culture. To generate mixed hemangioblast/cardiac colonies, blast colony growth was initiated in standard blast colony cultures containing Dox for 24 h. The developing colonies were then washed from with methylcellulose with IMDM containing 10% FCS to remove Dox. The colonies were recultured in blast colony methylcellulose supplemented with erythropoietin (2 U/ml) and IL-3 (1% conditioned medium). Mixed colonies containing an inner cardiac core surrounded by outer hematopoietic cells were picked for analysis at day 7.
Cardiac assay. Sorted cells were reaggregated for 24 h in StemPro-34 serum-free medium (Invitrogen) containing 2 mM L-glutamine, transferrin (200 mg/ml), 0.5 mM ascorbic acid and 4.5 Â 10 À4 M MTG at 1 Â 10 5 cells per ml in ultra-low-attachment 24-well plates. Single aggregates or pools of aggregates were replated in gelatin-coated 96-or 24-well plates containing StemPro with 2 mM L-glutamine for cardiac culture. VEGF at 5 ng/ml and basic FGF 30 ng/ml were added in the cardiac assay only for Bry-GFP + /Flk-1but not for Bry-GFP + /Flk-1 + cell differentiation. After 2 to 4 d of culture the proportion of aggregates containing contracting cells was scored and the number of Troponin T + cells was evaluated by flow cytometric analyses. For the aggregated and cardiac cultures, doxycycline (Dox) was used at 0.5 mg/ml and g-secretase inhibitor X at 5 mM (dissolved in DMSO). The same concentration of DMSO was added to the control cultures. Medium was changed every 2 d to provide fresh Dox and inhibitor if necessary.
Gene expression analysis. Gene expression analyses of colonies or small amount of mRNA was performed by polyA + global amplification PCRas previously described 48, 49 . Amplified PCR products were resolved on agarose gels and transferred to a Zeta-probe GT membrane (Bio-Rad). Genes of interest were then probed by 32 P randomly primed cDNA fragments (Ready-to-Go Labeling; Pharmacia) corresponding to the 3¢ regions of the genes. For genespecific PCR, total RNA was extracted from cells using the RNeasy mini-kit (Qiagen). One microgram total RNA was used to generate cDNAs by reverse transcription using the Omniscript RT kit (Qiagen) with random hexamer and then the cDNAs were subjected to PCR. The sequences of the cDNA fragments for probing the 3¢-regions of the genes and the primer sequences for genespecific PCR are available upon request. Real-time quantitative PCR was performed on a MasterCycler EP RealPlex (Eppendorf). Experiments were done in triplicate using Platinum SYBR GreenER qPCR SuperMix (Invitrogen). All annealing reactions were carried out at 60 1C.
Immunohistochemistry. Cell aggregates or colonies were plated on gelatincoated coverslips and cultured for 3-4 d in StemPro with 2 mM L-glutamine. Cells cultured on coverslips were fixed in 4% paraformaldehyde for 30 min, washed twice in PBS and permeabilized in 0.5% saponin/PBS for 10 min. Cells attached to the coverslips were incubated with a primary antibody for 2 h at 37 1C. After three washes, the cells on coverslips were incubated with a secondary antibody for 1 h in the dark. Finally, the coverslips were washed three times and then inverted onto a drop of DAPI (Vector Laboratories). Fluorescence was visualized using a Leica DMRA2 fluorescence microscope (Wetzlar) and recorded using a digital Hamamatsu CCD camera. The following antibodies were used for staining: anti-mouse CD31 from BD Biosciences Pharmingen, anti-mouse troponin T and anti-mouse SMA from NeoMarkers. The Cy2-, Cy3-and Cy5-conjugated secondary antibodies were purchased from Jackson ImmunoResearch.
Cell culture on Dll-1 expressing stromal cells. The OP9-DL1 cell line was a gift from Zuniga-Pflucker 40 . The OP9-DL1 cells were cultured in a 24-well plate and irradiated before use. Day 3.25 embryoid body-derived Flk-1 + cells (3 Â 10 4 per well) were seeded onto OP9 cells in the same medium used for the cardiac cultures. g-Secretase inhibitor X (dissolved in DMSO) at 5 mM or a corresponding volume of DMSO was included in the cultures. Medium was changed every day to supply fresh inhibitor. After 3 d of culture, the cells were harvested and subjected to flow cytometric analysis to determine the number of cTnT + cells.
Microarray analyses. mRNA expression was analyzed by CodeLink Microarray per manufacturer's instructions (CodeLink Express Assay Reagent Kit; GE Healthcare). Briefly, 1 mg of total RNA from each sample was reversetranscribed into cDNA using T7-(dT) 24 primers, and biotinylated cRNA prepared from this cDNA template by in vitro transcription. Ten micrograms of fragmented, biotinylated cRNA was hybridized to each CodeLink Mouse Whole Genome Array for 18 h at 37 1C. Afterwards, arrays were washed in 75 mM Tris-HCL, pH 7.6, 113 mM NaCl, 0.0375% Tween-20 for 1 h at 46 1C, then stained with a 1:500 dilution of streptavidin-Alexa 647 (Molecular Probes) for 30 min 22 1C. After the staining, arrays were washed three times, 5 min each, 22 1C with 0.1 M Tris-HCL, pH 7.6, 0.15 M NaCl, 0.05% Tween-20, then once with 0.1Â SSC/0.05% Tween for 30 s, then dried in a centrifuge. Processed arrays were scanned using a GenePix 4000B Scanner and GenePixPro v4 software (Axon Instruments). Images were analyzed using CodeLink Expression Analysis Software, and the raw intensity data exported into GeneSpring GX (Agilent Life Sciences), and raw intensity signals for each array were median normalized. Because some CodeLink probes were improperly annotated as to their intended target, refinement of gene-to-probe associations was accomplished by analysis using VistaGen's Fred knowledge base, which maps the genomic coordinates of probes with that of the exons of genes and provides various bioinformatics analytical and functional genomics tools. All genomic coordinates on the mouse genome build-36 were determined using BLAST. Invalid probes, such as the ones that target multiple genes or intergenic regions on the genome, were removed from subsequent analyses. The data from three experiments were averaged. One-way ANOVA (P o 0.05) was used to generate a set of probes with statistically significant differences between -Dox and +Dox treatments, using the Benjamini and Hochberg false discovery rate for multiple testing correction; the genes shown in Figure 5 are members of this ANOVA-qualified probe set.
Cardiac induction by cytokines and inhibitors.
The culture procedures to test the effects of cytokines and inhibitors on the cardiac differentiation from both Bry-GFP + /Flk-1and Bry-GFP + /Flk-1 + populations were the same as mentioned in the cardiac assay. To test the effects of Wnt3a and Wnt5a on the Doxinduced cardiomyogenesis, factors were added (150 ng/ml) individually to Dox to Bry-GFP + /Flk-1 + cells. Dox was maintained in culture for 24 h and Wnt for 48 h. To block BMP signaling, BMPR-1A and -1B were added (each at 1,500 ng/ ml) to the Bry-GFP + /Flk-1 + cells and maintained until cells were harvested. To recapitulate the cardiogenic effects of Notch4, BMP6 (0.1 and 1 ng/ml for Bry-GFP + /Flk-1 + and Bry-GFP + /Flk-1cells, respectively) and Wnt5a (150 ng/ml) were added directly to the sorted cells, whereas the addition of sFRP1 (500 ng/ml) was delayed for 18 h according to the expression patterns observed in our microarray analysis. The cytokines and inhibitor were removed from the culture at 48 h. Factors and inhibitors were tested at different concentrations. Optimal concentrations were used for the studies.
Accession number. The microarray data sets for Notch4-induced Flk-1 + cells are available with accession number GSE12425 in GEO (Gene Expression Omnibus) of NCBI.
Note: Supplementary information is available on the Nature Biotechnology website.
